Bortezomib and Gemcitabine in Treating Older Patients With Advanced Solid Tumors
Clinical trial NCT00620295 · COMPLETED
Trial details
- NCT number
- NCT00620295
- Sponsor
- Masonic Cancer Center, University of Minnesota
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2007-03-01
- Primary completion
- 2009-02-01
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.